Nivolumab Drug Substance from United States
Nivolumab Drug Substance is a bulk PD-1 blocking antibody for melanoma and lung cancer therapy. It is an unmixed immunological product obtained via biotechnological processes, not in measured doses or retail packs, and is classified under 3002.13.00.
Duty Rate — United States → Canada
0%
Import Tips
• Ensure the product is unmixed and in bulk form
• Keep batch records and certificates of analysis for CBSA
• Check if a Health Canada import permit is needed